← SynDRA

LANRAPLENIB

SynDRA canonical compound SYN0038682 — structure-anchored drug synonym record

All known targets

• SYK
• A1BG
• LAT
• TNK1

Mechanisms of action (all sources)

• SYK INHIBITOR
• Tyrosine-protein kinase SYK inhibitor
• tyrosine kinase inhibitor

Cross-references

• PubChem CID: 118161062
• ChEMBL: CHEMBL3986824
• DrugBank: DB14770
• KEGG: D11596
• PDB: R6D
• TTD: D0BW6F

Synonyms

• GS-SYK
• GS-9876
• XCIGZBVOUQVIPI-UHFFFAOYSA-N
• UNII-A6U64OU57E
• A6U64OU57E
• 6-(6-aminopyrazin-2-yl)-N-[4-[4-(oxetan-3-yl)piperazin-1-yl]phenyl]imidazo[1,2-a]pyrazin-8-amine
• 6-(6-Aminopyrazin-2-yl)-N-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidazo[1,2-a]pyrazin-8-amine
• Lanraplenib [INN]
• GTPL9764
• SCHEMBL16820581
• CHEMBL3986824
• example 2 [US9290505]
• BDBM212271
• GS9876
• US9290505, Ex.-2
• Ex.-2, US9290505
• Imidazo(1,2-a)pyrazin-8-amine, 6-(6-amino-2-pyrazinyl)-N-(4-(4-(3-oxetanyl)-1-piperazinyl)phenyl)-
• 6-(6-Aminopyr
• lanraplenibum
• RefChem:1088347
• Lanraplenib (GS-9876)
• Lanraplenib [USAN]
• Lanraplenib (USAN/INN)
• Lanraplenib [USAN:INN]
• LANRAPLENIB [WHO-DD]
• Lanraplenib (GS-9876)?
• orb1309494
• SCHEMBL29422916
• C23H25N9O
• GLXC-24275
• HMS5087H03
• AXC04695
• EX-A3747
• T11824LL
• s9715
• WHO 10601
• AKOS040733582
• compound 39 [PMID: 32292557]